178 related articles for article (PubMed ID: 1464737)
1. Cytokines and suppressor macrophages cause tumor-bearing host CD8+ T cells to suppress recognition of allogeneic and syngeneic MHC class II molecules.
Walker TM; Yurochko AD; Burger CJ; Elgert KD
J Leukoc Biol; 1992 Dec; 52(6):661-9. PubMed ID: 1464737
[TBL] [Abstract][Full Text] [Related]
2. Ia- macrophages and cytokine networks contribute to tumor-induced suppression of CD4+ autoreactive T cells.
Walker TM; Yurochko AD; Burger CJ; Elgert KD
Immunol Invest; 1993 Apr; 22(3):169-87. PubMed ID: 8099569
[TBL] [Abstract][Full Text] [Related]
3. Interferon-gamma reduces tumor-induced Ia- macrophage-mediated suppression: role of prostaglandin E2, Ia, and tumor necrosis factor-alpha.
Alleva DG; Burger CJ; Elgert KD
Immunopharmacology; 1993; 25(3):215-27. PubMed ID: 8354638
[TBL] [Abstract][Full Text] [Related]
4. Tumor growth increases Ia- macrophage synthesis of tumor necrosis factor-alpha and prostaglandin E2: changes in macrophage suppressor activity.
Alleva DG; Burger CJ; Elgert KD
J Leukoc Biol; 1993 May; 53(5):550-8. PubMed ID: 8388910
[TBL] [Abstract][Full Text] [Related]
5. Tumor growth alters macrophage responsiveness to macrophage colony-stimulating factor during reactivity against allogeneic and syngeneic MHC class II molecules.
Walker TM; Burger CJ; Elgert KD
Immunol Invest; 1993; 22(6-7):463-76. PubMed ID: 8262568
[TBL] [Abstract][Full Text] [Related]
6. Tumor growth changes the contribution of granulocyte-macrophage colony-stimulating factor during macrophage-mediated suppression of allorecognition.
Walker TM; Yurochko AD; Burger CJ; Elgert KD
Immunobiology; 1992 Sep; 185(5):427-39. PubMed ID: 1452214
[TBL] [Abstract][Full Text] [Related]
7. Tumour growth causes suppression of autoreactive T-cell proliferation by disrupting macrophage responsiveness to interferon-gamma.
Alleva DG; Burger CJ; Elgert KD
Scand J Immunol; 1994 Jan; 39(1):31-8. PubMed ID: 7904773
[TBL] [Abstract][Full Text] [Related]
8. Tumor-induced modulation of macrophage class II MHC molecule mRNA expression.
Askew D; Burger CJ; Elgert KD
Mol Immunol; 1993 Jul; 30(10):911-20. PubMed ID: 8341283
[TBL] [Abstract][Full Text] [Related]
9. Tumor modulation of autoreactivity: decreased macrophage and autoreactive T cell interactions.
Yurochko AD; Burger CJ; Elgert KD
Cell Immunol; 1990 Apr; 127(1):105-19. PubMed ID: 2138515
[TBL] [Abstract][Full Text] [Related]
10. Tumor growth changes responsiveness to and production of granulocyte-macrophage colony-stimulating factor during recognition of self MHC class II molecules.
Walker TM; Burger CJ; Elgert KD
Oncol Res; 1992; 4(11-12):455-65. PubMed ID: 1299376
[TBL] [Abstract][Full Text] [Related]
11. Increased sensitivity of tumor-bearing host macrophages to interleukin-10: a counter-balancing action to macrophage-mediated suppression.
Alleva DG; Burger CJ; Elgert KD
Oncol Res; 1994; 6(4-5):219-28. PubMed ID: 7841545
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 production by Mac-2+ macrophages: tumor-induced population shift.
Malick AP; Elgert KD; Garner RE; Adkinson NF
J Leukoc Biol; 1987 Dec; 42(6):673-81. PubMed ID: 2960767
[TBL] [Abstract][Full Text] [Related]
13. Fibrosarcoma-induced increase in macrophage tumor necrosis factor alpha synthesis suppresses T cell responses.
Alleva DG; Askew D; Burger CJ; Elgert KD
J Leukoc Biol; 1993 Aug; 54(2):152-60. PubMed ID: 8360594
[TBL] [Abstract][Full Text] [Related]
14. Promotion of macrophage-stimulated autoreactive T cell proliferation by interleukin-10: counteraction of macrophage suppressor activity during tumor growth.
Alleva DG; Elgert KD
Immunobiology; 1995 Feb; 192(3-4):155-71. PubMed ID: 7782092
[TBL] [Abstract][Full Text] [Related]
15. Tumor-induced alteration in macrophage accessory cell activity on autoreactive T cells.
Yurochko AD; Nagarkatti PS; Nagarkatti M; Elgert KD
Cancer Immunol Immunother; 1989; 30(3):170-6. PubMed ID: 2598186
[TBL] [Abstract][Full Text] [Related]
16. Tumor-induced macrophage tumor necrosis factor-alpha production suppresses autoreactive T cell proliferation.
Alleva DG; Burger CJ; Elgert KD
Immunobiology; 1993 Aug; 188(4-5):430-45. PubMed ID: 8244447
[TBL] [Abstract][Full Text] [Related]
17. Modulation of alloreactivity by Mac-1+, -2+, and -3+ macrophages from normal and tumor-bearing hosts: flow cytofluorometrically separated macrophages.
Askew D; Burger CJ; Elgert KD
Immunobiology; 1990 Dec; 182(1):1-10. PubMed ID: 2151512
[TBL] [Abstract][Full Text] [Related]
18. Tumor growth alters T cell and macrophage production of and responsiveness to granulocyte-macrophage colony-stimulating factor: partial dysregulation through interleukin-10.
Walker TM; Burger CJ; Elgert KD
Cell Immunol; 1994 Apr; 154(1):342-57. PubMed ID: 8131207
[TBL] [Abstract][Full Text] [Related]
19. Autoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma.
Harada M; Matsuzaki G; Yoshikai Y; Kobayashi N; Kurosawa S; Takimoto H; Nomoto K
Cancer Res; 1993 Jan; 53(1):106-11. PubMed ID: 8093229
[TBL] [Abstract][Full Text] [Related]
20. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production.
McMenamin C; Holt PG
J Exp Med; 1993 Sep; 178(3):889-99. PubMed ID: 8102390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
